Genpact Limited Director James C. Madden Sells 20,421 Shares (G)
Genpact Limited (NYSE:G) Director James C. Madden sold 20,421 shares of the stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $17.00, for a total transaction of $347,157.00. Following the completion of the transaction, the director now directly owns 13,426 shares in the company, valued at approximately $228,242. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Shares of Genpact Limited (NYSE:G) traded down 0.35% on Thursday, hitting $17.17. The stock had a trading volume of 950,682 shares. Genpact Limited has a 52 week low of $13.68 and a 52 week high of $21.30. The stock’s 50-day moving average is $17.05 and its 200-day moving average is $17.3. The company has a market cap of $4.007 billion and a P/E ratio of 17.60. Genpact Limited also was the target of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 2,467,333 shares, a decrease of 54.4% from the April 15th total of 5,412,777 shares. Based on an average trading volume of 545,132 shares, the days-to-cover ratio is presently 4.5 days. Approximately 1.4% of the shares of the stock are sold short.
Genpact Limited (NYSE:G) last released its earnings data on Monday, May 5th. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.23 by $0.01. The company had revenue of $528.20 million for the quarter, compared to the consensus estimate of $527.07 million. During the same quarter in the prior year, the company posted $0.23 earnings per share. The company’s quarterly revenue was up 4.8% on a year-over-year basis. Analysts expect that Genpact Limited will post $1.04 EPS for the current fiscal year.
A number of analysts have recently weighed in on G shares. Analysts at Zacks upgraded shares of Genpact Limited from a “neutral” rating to an “outperform” rating in a research note on Tuesday. They now have a $18.50 price target on the stock. Separately, analysts at Morgan Stanley reiterated an “equal weight” rating on shares of Genpact Limited in a research note on Tuesday, May 6th. They now have a $18.00 price target on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $17.79.
Genpact Limited (NYSE:G) is engaged in business process management and information technology services, leveraging the power of processes, analytics and technology to help its clients drive intelligence across their enterprises.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.